Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-10-16 4:31 pm Purchase | 13D | GELESIS HLDGS INC PAR VALU GLSHQ | PureTech Health LLC | 700,744,682 92.500% | 3,120,368 (+0.45%) | View |
| 2023-09-21 4:30 pm Purchase | 13D | GELESIS HLDGS INC PAR VALU GLSHQ | PureTech Health LLC | 697,624,314 92.500% | 697,624,314 (New Position) | View |
| 2023-06-29 4:30 pm Sale | 13D | GELESIS HLDGS INC PAR VALU GLSHQ | PureTech Health LLC | 0 0.000% | -655,172,572 (Position Closed) | View |
| 2023-06-13 5:25 pm Purchase | 13D | GELESIS HLDGS INC PAR VALU GLSHQ | PureTech Health LLC | 655,172,572 92.000% | 224,703,529 (+52.20%) | View |
| 2023-05-30 4:31 pm Purchase | 13D | GELESIS HLDGS INC PAR VALU GLSHQ | PureTech Health LLC | 430,469,043 88.400% | 52,163,000 (+13.79%) | View |
| 2023-05-02 07:38 am Purchase | 13D | GELESIS HLDGS INC PAR VALU GLSHQ | PureTech Health LLC | 378,306,043 87.000% | 378,306,043 (New Position) | View |
| 2023-04-20 5:16 pm Unchanged | 13D | GELESIS HLDGS INC PAR VALU GLSHQ | PureTech Health LLC | 0 0.000% | 0 (Unchanged) | View |
| 2023-04-04 06:50 am Unchanged | 13D | GELESIS HLDGS INC PAR VALU GLSHQ | PureTech Health LLC | 0 0.000% | 0 (Unchanged) | View |
| 2023-02-23 4:42 pm Unchanged | 13D | GELESIS HLDGS INC PAR VALU GLSHQ | PureTech Health LLC | 0 0.000% | 0 (Unchanged) | View |
| 2023-02-13 7:31 pm Sale | 13G | GELESIS HLDGS INC PAR VALU GLSHQ | PACIFIC INVESTMENT MANAGEMENT CO LLC | 3,760,000 4.900% | -6,063,876 (-61.73%) | View |
| 2023-02-13 4:02 pm Unchanged | 13G | GELESIS HLDGS INC PAR VALU GLSHQ | PERISCOPE CAPITAL INC. | 0 0.000% | 0 (Unchanged) | View |
| 2023-02-10 3:52 pm Sale | 13G | GELESIS HLDGS INC PAR VALU GLSHQ | ARISTEIA CAPITAL L.L.C. | 727,836 0.990% | -684,806 (-48.48%) | View |
| 2022-12-30 4:30 pm Purchase | 13D | GELESIS HLDGS INC PAR VALU GLSHQ | SSD2 LLC | 13,433,267 18.050% | 27,535 (+0.21%) | View |
| 2022-08-04 4:46 pm Sale | 13D | GELESIS HLDGS INC PAR VALU GLSHQ | PureTech Health LLC | 0 0.000% | -17,099,310 (Position Closed) | View |
| 2022-07-20 06:02 am Purchase | 13G | GELESIS HLDGS INC PAR VALU GLSHQ | CMS Medical Venture Investment (HK) Ltd | 4,501,770 6.200% | 4,501,770 (New Position) | View |
| 2022-02-22 06:01 am Purchase | 13G | GELESIS HLDGS INC PAR VALU GLSHQ | Capstar Sponsor Group LLC | 14,357,000 34.200% | 14,357,000 (New Position) | View |
| 2022-02-14 5:05 pm Purchase | 13G | GELESIS HLDGS INC PAR VALU GLSHQ | PERISCOPE CAPITAL INC. | 1,400,000 5.070% | 1,400,000 (New Position) | View |
| 2022-02-14 4:11 pm Sale | 13G | GELESIS HLDGS INC PAR VALU GLSHQ | GLAZER CAPITAL LLC | 1,248,329 4.520% | -273,767 (-17.99%) | View |
| 2022-02-14 11:40 am Unchanged | 13G | GELESIS HLDGS INC PAR VALU GLSHQ | MARSHALL WACE LLP | 0 0.000% | 0 (Unchanged) | View |
| 2022-02-14 08:46 am Purchase | 13G | GELESIS HLDGS INC PAR VALU GLSHQ | ARISTEIA CAPITAL L.L.C. | 1,412,642 5.120% | 1,412,642 (New Position) | View |